- 現金殖利率: 5.92%、總殖利率: 5.92%、5年平均現金配發率: 111.32%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 (5) | 1.68 | 12.0 | 1.40 | 7.69 | 0.00 | 0 | 83.33 | -3.85 | 0.00 | 0 | 83.33 | -3.85 |
| 2024 (4) | 1.50 | 525.0 | 1.30 | 160.0 | 0.00 | 0 | 86.67 | -58.4 | 0.00 | 0 | 86.67 | -58.4 |
| 2023 (3) | 0.24 | -52.0 | 0.50 | -37.5 | 0.00 | 0 | 208.33 | 30.21 | 0.00 | 0 | 208.33 | 30.21 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 26Q1 (8) | 0.11 | 10.0 | -35.29 | -0.04 | -130.77 | -300.0 | 0.11 | -93.45 | -35.29 |
| 25Q4 (7) | 0.10 | -83.61 | -23.08 | 0.13 | -62.86 | 750.0 | 1.68 | 6.33 | 12.0 |
| 25Q3 (6) | 0.61 | -23.75 | -16.44 | 0.35 | 483.33 | -42.62 | 1.58 | 62.89 | 15.33 |
| 25Q2 (5) | 0.80 | 370.59 | 40.35 | 0.06 | 700.0 | -68.42 | 0.97 | 470.59 | 51.56 |
| 25Q1 (4) | 0.17 | 30.77 | 0.0 | -0.01 | 50.0 | 0.0 | 0.17 | -88.67 | 0.0 |
| 24Q4 (3) | 0.13 | -82.19 | 0.0 | -0.02 | -103.28 | 0.0 | 1.50 | 9.49 | 0.0 |
| 24Q3 (2) | 0.73 | 28.07 | 0.0 | 0.61 | 221.05 | 0.0 | 1.37 | 114.06 | 0.0 |
| 24Q2 (1) | 0.57 | 0.0 | 0.0 | 0.19 | 0.0 | 0.0 | 0.64 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/4 | 1.98 | 27.55 | 27.19 | 7.04 | 3.7 | 4.77 | N/A | - | ||
| 2026/3 | 1.55 | 25.06 | -23.25 | 5.06 | -3.27 | 5.06 | 1.19 | - | ||
| 2026/2 | 1.24 | -45.42 | 23.5 | 3.51 | 9.29 | 5.66 | 1.06 | - | ||
| 2026/1 | 2.27 | 5.59 | 2.84 | 2.27 | 2.84 | 6.48 | 0.93 | - | ||
| 2025/12 | 2.15 | 4.46 | 7.23 | 24.99 | -5.33 | 6.1 | 0.9 | - | ||
| 2025/11 | 2.06 | 8.7 | -0.73 | 22.84 | -6.36 | 6.07 | 0.91 | - | ||
| 2025/10 | 1.89 | -10.68 | -15.27 | 20.78 | -6.89 | 6.76 | 0.81 | - | ||
| 2025/9 | 2.12 | -22.87 | -31.97 | 18.88 | -5.95 | 7.13 | 0.8 | - | ||
| 2025/8 | 2.75 | 21.86 | -18.59 | 16.76 | -1.17 | 7.96 | 0.71 | - | ||
| 2025/7 | 2.26 | -23.67 | 5.13 | 14.01 | 3.15 | 7.22 | 0.79 | - | ||
| 2025/6 | 2.96 | 46.95 | 8.11 | 11.76 | 2.78 | 6.52 | 0.82 | - | ||
| 2025/5 | 2.01 | 29.38 | -0.64 | 8.8 | 1.1 | 5.59 | 0.96 | - | ||
| 2025/4 | 1.55 | -23.03 | -34.82 | 6.79 | 1.64 | 4.58 | 1.17 | - | ||
| 2025/3 | 2.02 | 101.27 | 9.95 | 5.23 | 21.9 | 5.23 | 1.04 | - | ||
| 2025/2 | 1.0 | -54.55 | 103.89 | 3.21 | 30.85 | 5.22 | 1.05 | 因前期偏低 | ||
| 2025/1 | 2.21 | 10.1 | 12.53 | 2.21 | 12.53 | 6.29 | 0.87 | - | ||
| 2024/12 | 2.01 | -3.3 | 23.49 | 26.39 | 13.24 | 6.32 | 0.89 | - | ||
| 2024/11 | 2.07 | -7.21 | -2.8 | 24.39 | 12.47 | 7.43 | 0.76 | - | ||
| 2024/10 | 2.24 | -28.29 | 9.94 | 22.31 | 14.14 | 8.73 | 0.64 | - | ||
| 2024/9 | 3.12 | -7.69 | 39.36 | 20.08 | 14.63 | 8.64 | 0.58 | - | ||
| 2024/8 | 3.38 | 57.38 | 49.13 | 16.96 | 11.01 | 8.26 | 0.61 | - | ||
| 2024/7 | 2.15 | -21.51 | -21.73 | 13.58 | 4.38 | 6.91 | 0.73 | - | ||
| 2024/6 | 2.73 | 35.04 | 45.39 | 11.44 | 11.35 | 7.14 | 0.67 | - | ||
| 2024/5 | 2.02 | -15.11 | -26.14 | 8.7 | 3.72 | 6.25 | 0.77 | - | ||
| 2024/4 | 2.39 | 29.84 | 31.72 | 6.68 | 18.22 | 4.72 | 1.02 | - | ||
| 2024/3 | 1.84 | 273.21 | 8.19 | 4.29 | 11.84 | 4.29 | N/A | - | ||
| 2024/2 | 0.49 | -74.91 | -14.02 | 2.45 | 14.75 | 4.08 | N/A | - | ||
| 2024/1 | 1.96 | 20.82 | 25.26 | 1.96 | 25.26 | 5.72 | N/A | - | ||
| 2023/12 | 1.62 | -23.89 | -13.21 | 23.31 | -33.23 | 5.79 | N/A | - | ||
| 2023/11 | 2.13 | 4.95 | -3.5 | 21.68 | -34.36 | 6.4 | N/A | - | ||
| 2023/10 | 2.03 | -9.11 | -24.28 | 19.55 | -36.58 | 6.54 | N/A | - | ||
| 2023/9 | 2.24 | -1.22 | -8.01 | 17.52 | -37.75 | 7.24 | N/A | - | ||
| 2023/8 | 2.26 | -17.4 | 12.32 | 15.28 | -40.56 | 6.89 | N/A | - | ||
| 2023/7 | 2.74 | 45.81 | -13.99 | 13.01 | -45.07 | 7.36 | N/A | - | ||
| 2023/6 | 1.88 | -31.4 | -43.15 | 10.27 | -49.9 | 6.43 | N/A | - | ||
| 2023/5 | 2.74 | 51.39 | -27.53 | 8.39 | -51.2 | 6.25 | N/A | 因疫情影響,導致營收減少 | ||
| 2023/4 | 1.81 | 6.64 | -49.78 | 5.65 | -57.88 | 4.08 | N/A | 因疫情影響,導致營收減少 | ||
| 2023/3 | 1.7 | 196.58 | -38.23 | 3.84 | -60.85 | 3.84 | N/A | 因疫情影響,導致營收減少 | ||
| 2023/2 | 0.57 | -63.45 | -72.6 | 2.14 | -69.67 | 4.01 | N/A | 因疫情影響,導致營收減少 | ||
| 2023/1 | 1.57 | -16.29 | -68.44 | 1.57 | -68.44 | 5.65 | N/A | 因疫情影響,導致營收減少 | ||
| 2022/12 | 1.87 | -15.37 | -51.36 | 34.91 | -7.25 | 6.77 | N/A | 因疫情影響,導致營收減少 | ||
| 2022/11 | 2.21 | -17.64 | -43.41 | 33.04 | -2.23 | 7.33 | N/A | - | ||
| 2022/10 | 2.69 | 10.41 | -22.57 | 30.83 | 3.15 | 7.13 | N/A | - | ||
| 2022/9 | 2.43 | 20.6 | -34.06 | 28.14 | 6.53 | 7.64 | N/A | - | ||
| 2022/8 | 2.02 | -36.75 | -35.62 | 25.71 | 13.11 | 8.51 | N/A | - | ||
| 2022/7 | 3.19 | -3.61 | -0.71 | 23.69 | 20.91 | 10.28 | N/A | - | ||
| 2022/6 | 3.31 | -12.56 | 4.2 | 20.5 | 25.15 | 10.7 | N/A | - | ||
| 2022/5 | 3.78 | 4.91 | 21.8 | 17.19 | 30.18 | 10.14 | N/A | - | ||
| 2022/4 | 3.61 | 31.17 | 25.95 | 13.41 | 32.76 | 8.45 | N/A | - | ||
| 2022/3 | 2.75 | 31.55 | 21.57 | 9.8 | 35.45 | 9.8 | N/A | - | ||
| 2022/2 | 2.09 | -57.9 | 6.62 | 7.05 | 41.76 | 10.9 | N/A | - | ||
| 2022/1 | 4.96 | 29.01 | 64.59 | 4.96 | 64.59 | 12.72 | N/A | 2021年因COVID-19影響出貨減少. | ||
| 2021/12 | 3.85 | -1.55 | 21.5 | 37.64 | 23.27 | 11.23 | N/A | - | ||
| 2021/11 | 3.91 | 12.7 | 9.98 | 33.79 | 23.47 | 11.07 | N/A | - | ||
| 2021/10 | 3.47 | -5.96 | 10.1 | 29.88 | 25.49 | 10.29 | N/A | - | ||
| 2021/9 | 3.69 | 17.74 | 9.01 | 26.41 | 27.84 | 10.03 | N/A | - | ||
| 2021/8 | 3.13 | -2.45 | 11.54 | 22.73 | 31.52 | 9.52 | N/A | - | ||
| 2021/7 | 3.21 | 1.15 | 59.5 | 19.59 | 35.4 | 9.49 | N/A | 受新冠疫情響產能減少 | ||
| 2021/6 | 3.17 | 2.2 | 21.5 | 16.38 | 31.51 | 0.0 | N/A | - | ||
| 2021/5 | 3.11 | 8.48 | 52.13 | 13.21 | 34.16 | 0.0 | N/A | 109年大陸廠因受COVID-19 影響產能大減 |